Sign Up to like & get
recommendations!
0
Published in 2017 at "Chest"
DOI: 10.1016/j.chest.2016.11.028
Abstract: Background: Long‐acting muscarinic antagonist (LAMA)/long‐acting &bgr;2‐agonist (LABA) combinations are a treatment option for patients with COPD who continue to have symptoms despite treatment with a LAMA or a LABA alone. The Efficacy and Safety of…
read more here.
Keywords:
efficacy safety;
mdi;
inhaler;
safety ... See more keywords